Sunday, October 3, 2010
Fresenius Kabi Recalls India Unit Drug From U.S.: Report
MUMBAI - Indian drugmaker Fresenius Kabi Oncology Ltd has seen two batches of a cancer drug shipped to the U.S. being recalled by its German parent, Fresenius Kabi Pharmaceuticals Holdin Inc, the Economic Times reported on Monday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment